Gan & Lee Pharmaceuticals Co., Ltd. Class ASSE: 603087

Announcement on Positive CHMP Opinion Received for Marketing Authorization Application (MAA) of Insulin Glargine Injection (Ondibta?)

· Issued by Gan & Lee Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Positive CHMP Opinion Received for Marketing Authorization Application (MAA) of Insulin Glargine Injection (Ondibta?)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis